WHRT's market cap is roughly the same as it was when the current investors recapitalized the company approximately 2 years ago. Since then they've gotten the LVAD approved, started clinical trials, and begun generating revenue. Yet, you can buy in today at half of what insiders just paid in January. <br /> <br /> When one considers that 100,000 patients need transplants each year but only 2,000 get them, I believe the market for LVAD's is going to grow significantly. Whether World Hearts device will be one of the winners remains to be seen but considering HTWR's market cap is over 800 million, I like the upside.